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Letters to the Editor 
Dear Editor 
Kikuchi’s disease and systemic lupus 
erythematosus 
We read with interest the case report by Abba 
et al. (1) on Kikuchi’s disease presenting as 
bilateral hilar lymphadenopathy. We feel the 
report fails to stress the importance of the associ- 
ation between histiocytic necrotizing lymphad- 
enitis (HNL) and connective tissue diseases, in 
particular systemic lupus erythematosus (SLE). 
We recently investigated a 29-year-old female 
with fever, cervical lymphadenopathy and a pru- 
ritic maculo-papular rash on the trunk and arms. 
The clinical picture was typical of other reports 
of Kikuchi’s disease (2). Lymph node biopsy 
showed the ‘pathognomic’ features of Kikuchi’s 
disease. The histological appearances were 
confirmed by independent review. 
Over the following months, she developed a 
more florid rash with inflammatory plaques of 
discoid lupus, confirmed on skin biopsy. Her 
vision deteriorated in the left eye with retinal 
abnormalities consistent with SLE. Autoanti- 
body screening confirmed the diagnosis of SLE 
with positive ANA and antibodies to double- 
stranded DNA. She has been treated by pred- 
nisolone and hydroxychloroquine, and is 
currently in remission. 
The pathological feature of HNL in associ- 
ation with SLE has been reported in a small 
number of patients, and the SLE may be 
extremely florid in its activity (3,4). Our patients 
with SLE still required significant immuno- 
suppressant treatment to suppress disease 
activity. 
Like many reports on Kikuchi’s disease, the 
report by Abba et al. continues to reinforce 
HNL as a brief benign self-limiting condition, 
and only mentions in passing the association 
with other systemic conditions. They have not 
excluded SLE or overlap syndrome in their 
patient, on the basis of the investigations 
reported. 
It is essential that clinicians and pathologists 
appreciate that some patients with a pathologi- 
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cal diagnosis of HNL may have severe, poten- 
tially life-threatening disorders. It may be best to 
avoid the term ‘Kikuchi’s disease’, and simply 
describe the pathological feature of histiocytic 
necrotizing lymphadenitis. 
C. W. H. DAVIES AND C. G. WATHEN 
Department of Thovacic Medicine 
Wycombe General Hospital 
High Wycombe, U.K. 
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Reply to Drs Davies and Wathen 
We appreciate the comments made by Drs 
Davies and Wathen on our report and agree with 
them fully that some patients presenting with 
Kikuchi’s disease may indeed have potentially 
life-threatening disorders. This underlines the 
need for close follow-up of all patients with the 
histological diagnosis of histiocytic necrotizing 
lymphadenitis (HNL). As mentioned in our 
report, HNL and SLE share certain histopatho- 
logical characteristics and indeed not less than 
13 cases have been reported in the literature 
associating HNL and SLE (1). We have 
followed-up nine patients (of a group of 13 seen 
in our hospital) with histological diagnosis of 
HNL for at least 18 months. In all patients, 
lymphadenopathy and other symptoms subsided 
and no other features of connective tissue disease 
manifested. One of our patients with mixed 
connective tissue disease (MCTD) developed 
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